Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-25-211788

Chief Operating Officer sold 10,000 shares at $115.96 ($1,159,600)

  • Chief Operating Officer acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jacobson Mark L. Chief Operating Officer 2025-09-22 Option exercise 10b5-1 +10,000 $2.85 $28,500 10,000 D
Jacobson Mark L. Chief Operating Officer 2025-09-22 Sale 10b5-1 −10,000 $115.96 $1,159,600 0 D
Derivatives
Jacobson Mark L. Chief Operating Officer 2025-09-22 Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 35,378 D
Open-market sales · 10,000 sh · avg $115.96 · $1,159,600
Loading xslF345X05/ownership.xml…